Sufferers of chronic pain have long been told it’s all in their head. We now know that’s wrong.
Linda Geddes, The Guardian - 2021
Swing Therapeutics is committed to furthering the availability of comprehensive, evidence-based digital treatments. See why we’re excited about the possibilities.
Swing Therapeutics believes in taking a scientifically rigorous approach to clinically validate the impact of our treatments. We stand on the shoulders of ground-breaking research performed by global leaders in the field. This foundation of evidence guides our product roadmap. Our collaborations help us achieve our mission of supporting people with chronic illnesses in leading their best lives.
Learn more about Swing’s clinical trials Learn more about our collaborators and advisorsFibromyalgia patients who underwent CBT showed reduced resting state connectivity between S1 and anterior/medial insula after treatment compared to an education control, which were concurrent with treatment-related reductions in pain catastrophizing.
View StudyACT delivered online showed significant improvement in fibromyalgia impact, depression and pain, compared to wait list control. Swing Therapeutics has exclusively licensed this program, and it is the foundation of our digital therapeutic in development.
View StudyACT delivered in a group setting showed significant improvement in fibromyalgia impact compared to both recommended pharmacologic treatment and wait list control, with improvements maintained at six months.
View StudyA Web-Enhanced Behavioral Self-Management program for fibromyalgia delivered online demonstrated significant improvements in pain, physical functioning, and overall global improvement compared to a wait list control.
View StudyACT was less costly and more effective than recommended drugs in fibromyalgia.
View StudyLinda Geddes, The Guardian - 2021
Karen Barrow, The New York Times - 2018